Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives
- 22 September 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (22) , 5703-5707
- https://doi.org/10.1016/j.bmcl.2004.07.085
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IXJournal of Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IXBioorganic & Medicinal Chemistry Letters, 2004
- Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Tumor-Associated Isozyme IX with Sulfamates Including EMATE Also Acting as Steroid Sulfatase InhibitorsJournal of Medicinal Chemistry, 2003
- Carbonic Anhydrase Inhibitors. Inhibition of Tumor-Associated Isozyme IX by Halogenosulfanilamide and Halogenophenylaminobenzolamide DerivativesJournal of Medicinal Chemistry, 2003
- Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamidesBioorganic & Medicinal Chemistry Letters, 2003
- Indisulam: an anticancer sulfonamide in clinical developmentExpert Opinion on Investigational Drugs, 2003
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Applications of carbonic anhydrase inhibitors and activators in therapyExpert Opinion on Therapeutic Patents, 2002